Similar Search Results

Pharmaceutical advertising and Medicare Part D

Lakdawalla, Darius; Sood, Neeraj; Gu, Qian - In: Journal of health economics 32 (2013) 6, pp. 1356-1367

Persistent link: https://www.econbiz.de/10010425165

Patient responses to incentives in consumer-directed health plans : evidence from pharmaceuticals

Huckfeldt, Peter J.; Haviland, Amelia; Mehrotra, Ateev; … - 2015

Persistent link: https://www.econbiz.de/10010495476

Patient Responses to Incentives in Consumer-directed Health Plans : Evidence from Pharmaceuticals

Huckfeldt, Peter J. - 2015

use of pharmaceuticals for chronic diseases. We compare two large firms where nearly all employees were switched to CDHPs … to firms with conventional health insurance plans. In the first firm's CDHP, pharmaceuticals were subject to the … deductible, while in the second firm pharmaceuticals were exempt. Employees in the first firm shifted the timing of drug …

Persistent link: https://www.econbiz.de/10012457739

Patient Responses to Incentives in Consumer-Directed Health Plans : Evidence from Pharmaceuticals

Huckfeldt, Peter J. - 2015

Persistent link: https://www.econbiz.de/10013028554

Prescription drug advertising and drug utilization : the role of Medicare Part D

Alpert, Abby; Lakdawalla, Darius; Sood, Neeraj - 2015

Persistent link: https://www.econbiz.de/10011418907

Prescription Drug Advertising and Drug Utilization : The Role of Medicare Part D

Alpert, Abby - 2015

Pharmaceutical firms currently spend over $4 billion on direct-to-consumer advertising (DTCA) of prescription drugs, a nearly 30-fold increase since 1993 that has led to much debate about its value to patients. We examine how DTCA influences drug utilization along the extensive and intensive...

Persistent link: https://www.econbiz.de/10013011931